Physician Resources
Featured Content |Browse All Content
Course
An Overview of Common Complications with Structural Heart Disease
The leading treatment option for AS and other structural diseases is transcatheter aortic valve replacement (TAVR). The overall complication rate of TAVR is relatively low -- around 4%. However, patients who experience complications have ...
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective ...
Course
Pleural Effusions and Pleural Disease
Pleural disease is a common but frequently misunderstood clinical entity within the field of pulmonary disease. While up to 30% of individuals assessed may have pleural effusions, the specific diagnostic and therapeutic modalities undertaken ...
Video
Pulmonary Arterial Hypertension and RV Failure
The average time from symptom onset to accurate diagnosis of pulmonary arterial hypertension (PAH) is 2.8 years, and more than half of patients have already progressed to functional class 3 or 4 by the time of diagnosis. Overlapping symptoms ...
Video
REBIRTH Trial: Evaluating Bromocriptine Therapy for Peripartum Cardiomyopathy
In this presentation, Dr. Deborah Crabbe, Cardiologist at Temple University Hospital and Professor of Medicine at Lewis Katz School of Medicine at Temple University, outlines the REBIRTH Trial, a randomized trial that reviews the use of ...
